Meloxicam Completed Phase 1 Trials for Healthy Volunteers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03684265A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets
NCT02183090Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy Subjects
NCT02183077Pharmacokinetics and Tolerability of Meloxicam Gel Compared to Meloxicam Tablets in Healthy Subjects
NCT02183142Study of Relative Bioavailability of Mobic Manufactured in China in Comparison With Mobic Manufactured in Germany in Chinese Healthy Volunteers
NCT02183181Bioequivalence Study of Meloxicam Capsules 15 mg (MobicĀ® Capsules 15 mg) Versus Meloxicam Tablets 15 mg (MobicĀ® Tablets 15 mg) in Healthy Adult Volunteers
NCT02181309Effect of Food on the Pharmacokinetics of Meloxicam in Healthy Volunteers
NCT02187562Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and Females
NCT01161147Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition
NCT01161134Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition